What is Coapt?
Coapt specializes in the development of its Complete Control system, which leverages sophisticated machine-learning algorithms to decode muscle signal patterns. This technology enables a more natural and intuitive control experience for individuals using upper limb prosthetics, addressing challenges faced by amputees and those with congenital limb differences. The Gen2 system's compatibility with most existing myoelectric prosthetic components makes Coapt's advanced solutions widely accessible, aiming to significantly improve the quality of life for its users through revolutionary prosthetic development.
How much funding has Coapt raised?
Coapt has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Coapt
PPP
Public-Private Partnership
What's next for Coapt?
With the recent strategic investment, Coapt is poised for accelerated expansion and further refinement of its groundbreaking technology. The substantial capital infusion is expected to fuel research and development, enhance manufacturing capabilities, and broaden market reach. This late-stage funding suggests a focus on scaling operations and solidifying Coapt's position as a dominant force in the prosthetics industry, potentially leading to new product iterations and strategic partnerships to further its mission of empowering amputees.
See full Coapt company page
